 Parler
 Parler Gab
 Gab
 2)This German study showed
SOURCE: Risk of Hospitalization, severe disease, and mortality due to COVID-19 and PIMS-TS in children with SARS-CoV-2 infection in Germany
“Children without comorbidities were found to be significantly less likely to suffer from a severe or fatal disease course. The lowest risk was observed in children aged 5-11 without comorbidities. In this group, the ICU admission rate was 0.2 per 10,000 and case fatality could not be calculated, due to an absence of cases.”
3)This Swedish seminal study found
SOURCE: Open Schools, Covid-19, and Child and Teacher Morbidity in Sweden
“From March through June 2020, a total of 15 children with Covid-19 (including those with MIS-C) were admitted to an ICU (0.77 per 100,000 children in this age group) (Table 1), 4 of whom were 1 to 6 years of age (0.54 per 100,000) and 11 of whom were 7 to 16 years of age (0.90 per 100,000). Four of the children had an underlying chronic coexisting condition (cancer in 2, chronic kidney disease in 1, and hematologic disease in 1). No child with Covid-19 died.”
4)This study by Dr. Marty Makary and Johns Hopkins found (see graph)
SOURCE: A FAIR Health White Paper in Collaboration with the West Health Institute and Marty Makary, MD, MPH, from Johns Hopkins University School of Medicine, November 11, 2020
2)This German study showed
SOURCE: Risk of Hospitalization, severe disease, and mortality due to COVID-19 and PIMS-TS in children with SARS-CoV-2 infection in Germany
“Children without comorbidities were found to be significantly less likely to suffer from a severe or fatal disease course. The lowest risk was observed in children aged 5-11 without comorbidities. In this group, the ICU admission rate was 0.2 per 10,000 and case fatality could not be calculated, due to an absence of cases.”
3)This Swedish seminal study found
SOURCE: Open Schools, Covid-19, and Child and Teacher Morbidity in Sweden
“From March through June 2020, a total of 15 children with Covid-19 (including those with MIS-C) were admitted to an ICU (0.77 per 100,000 children in this age group) (Table 1), 4 of whom were 1 to 6 years of age (0.54 per 100,000) and 11 of whom were 7 to 16 years of age (0.90 per 100,000). Four of the children had an underlying chronic coexisting condition (cancer in 2, chronic kidney disease in 1, and hematologic disease in 1). No child with Covid-19 died.”
4)This study by Dr. Marty Makary and Johns Hopkins found (see graph)
SOURCE: A FAIR Health White Paper in Collaboration with the West Health Institute and Marty Makary, MD, MPH, from Johns Hopkins University School of Medicine, November 11, 2020
 5) This study by Dorabawila et al. showed
SOURCE: Effectiveness of the BNT162b2 vaccine among children 5-11 and 12-17 years in New York after the Emergence of the Omicron Variant
“In the Omicron era, the effectiveness against cases of BNT162b2 declined rapidly for children, particularly those 5-11 years…From December 13, 2021 to January 30, 2022, among 852,384 fully-vaccinated children 12-17 years and 365,502 children 5-11 years, VE against cases declined from 66% (95% CI: 64%, 67%) to 51% (95% CI: 48%, 54%) for those 12-17 years and from 68% (95% CI: 63%, 72%) to 12% (95% CI: 6%, 16%) for those 5-11 years.”
6)This WSJ report shows that Nordic nations suspended Moderna’s vaccines in children
SOURCE: Some European Countries Are Limiting the Use of Moderna’s Covid-19 Vaccine in Younger Ages; Finland, Sweden, Denmark and Norway take precautionary measures amid concerns over rare cardiovascular side effects
“Finland on Thursday joined Sweden, Denmark and Norway in recommending against use of Moderna Covid-19 vaccine in younger age groups, citing risks of rare cardiovascular side effects they said warranted the precautionary steps.”
7)The FDA’s June 15th report is a very frightening report, see page 39, Tables 19 and 20 as to the negative efficacy post Dose 1 to before Dose 2
SOURCE:
Vaccines and Related Biological Products Advisory Committee Meeting June 15, 2022
5) This study by Dorabawila et al. showed
SOURCE: Effectiveness of the BNT162b2 vaccine among children 5-11 and 12-17 years in New York after the Emergence of the Omicron Variant
“In the Omicron era, the effectiveness against cases of BNT162b2 declined rapidly for children, particularly those 5-11 years…From December 13, 2021 to January 30, 2022, among 852,384 fully-vaccinated children 12-17 years and 365,502 children 5-11 years, VE against cases declined from 66% (95% CI: 64%, 67%) to 51% (95% CI: 48%, 54%) for those 12-17 years and from 68% (95% CI: 63%, 72%) to 12% (95% CI: 6%, 16%) for those 5-11 years.”
6)This WSJ report shows that Nordic nations suspended Moderna’s vaccines in children
SOURCE: Some European Countries Are Limiting the Use of Moderna’s Covid-19 Vaccine in Younger Ages; Finland, Sweden, Denmark and Norway take precautionary measures amid concerns over rare cardiovascular side effects
“Finland on Thursday joined Sweden, Denmark and Norway in recommending against use of Moderna Covid-19 vaccine in younger age groups, citing risks of rare cardiovascular side effects they said warranted the precautionary steps.”
7)The FDA’s June 15th report is a very frightening report, see page 39, Tables 19 and 20 as to the negative efficacy post Dose 1 to before Dose 2
SOURCE:
Vaccines and Related Biological Products Advisory Committee Meeting June 15, 2022
 
 8)CDC planned meetings to authorize the fraud injections
SOURCE:
CDC agenda June 17th and 18th, note that they plan to vote for the COVID injection for our young children
Read more at: PAlexander.Substack.com
8)CDC planned meetings to authorize the fraud injections
SOURCE:
CDC agenda June 17th and 18th, note that they plan to vote for the COVID injection for our young children
Read more at: PAlexander.Substack.com
They are screwing with the weather maps: SUN is BAD!
By News Editors // Share
“Morally and intellectually corrupt”: UCLA professor resigns in protest over viewpoint intolerance
By News Editors // Share
Here are SEVEN MEDICINAL TEAS and the best time to drink them for max benefit
By ljdevon // Share
Trump repositions nuclear subs, resumes testing as Russia advances hypersonic missiles, drones
By finnheartley // Share
SNAP benefits and Russian nuclear threat: Dual crises highlight economic and geopolitical tensions
By finnheartley // Share
U.S. militarizes Indo-Pacific: A new front in the China showdown
By gregoryv // Share